Literature DB >> 4398931

Protection against induction of supersensitivity to catecholamines by cocaine.

I R Innes, G W Karr.   

Abstract

1. Adrenaline, noradrenaline, isoprenaline, tyramine, phentolamine, pronethalol, histamine and acetylcholine were each tested for their ability to prevent cocaine from causing supersensitivity to catecholamines in cat spleen strips in vitro. A high concentration of one of these drugs was added to the bath 5 min before cocaine hydrochloride (10 mug/ml). The effect on subsequent responses to catecholamines was compared with the effect of cocaine in control strips in the absence of an interfering drug.2. Phentolamine completely abolished the potentiating effect of cocaine. Large doses of adrenaline or noradrenaline reduced, but did not completely prevent, potentiation. Tyramine, isoprenaline, pronethalol, histamine and acetylcholine did not prevent potentiation.3. The ability of these drugs to interfere with potentiation does not correlate well with their ability to interfere with uptake of noradrenaline. Interference with uptake by cocaine is therefore unlikely to account fully for potentiation.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4398931      PMCID: PMC1665740          DOI: 10.1111/j.1476-5381.1971.tb07144.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  ACTIONS AND INTERACTIONS OF NOREPINEPHRINE, TYRAMINE AND COCAINE ON AORTIC STRIPS OF RABBIT AND LEFT ATRIA OF GUINEA PIG AND CAT.

Authors:  R F FURCHGOTT; S M KIRPEKAR; M RIEKER; A SCHWAB
Journal:  J Pharmacol Exp Ther       Date:  1963-10       Impact factor: 4.030

2.  Allosteric proteins and cellular control systems.

Authors:  J MONOD; J P CHANGEUX; F JACOB
Journal:  J Mol Biol       Date:  1963-04       Impact factor: 5.469

3.  Supersensitivity and subsensitivity to sympathomimetic amines.

Authors:  U TRENDELENBURG
Journal:  Pharmacol Rev       Date:  1963-06       Impact factor: 25.468

4.  The action of sympathomimetic amines in animals treated with reserpine.

Authors:  J H BURN; M J RAND
Journal:  J Physiol       Date:  1958-12-04       Impact factor: 5.182

5.  Dibenamine blockade in strips of rabbit aorta and its use in differentiating receptors.

Authors:  R F FURCHGOTT
Journal:  J Pharmacol Exp Ther       Date:  1954-07       Impact factor: 4.030

6.  Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines.

Authors:  U Trendelenburg
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

7.  Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline.

Authors:  G HERTTING; J AXELROD; R W PATRICK
Journal:  Br J Pharmacol Chemother       Date:  1962-02

8.  A hypothesis concerning the effect of cocaine on the action of sympathomimetic amines.

Authors:  W H MACMILLAN
Journal:  Br J Pharmacol Chemother       Date:  1959-09

9.  An action of 5-hydroxytryptamine on adrenaline receptors.

Authors:  I R INNES
Journal:  Br J Pharmacol Chemother       Date:  1962-12

10.  Effect of cocaine and related drugs on the uptake of noradrenaline by heart and spleen.

Authors:  E MUSCHOLL
Journal:  Br J Pharmacol Chemother       Date:  1961-06
View more
  4 in total

1.  Effect of cocaine on the affinity of -adrenoceptors for noradrenaline.

Authors:  I R Innes; R Mailhot
Journal:  Br J Pharmacol       Date:  1973-05       Impact factor: 8.739

2.  The role of bound calcium in supersensitivity induced by cocaine.

Authors:  R Greenberg; I R Innes
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

3.  Investigation of the role of calcium in the supersensitivity produced by cocaine in cat spleen strips.

Authors:  R J Summers; J Tillman
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

4.  Multiple actions of cocaine on neuromuscular transmission and smooth muscle cells of the guinea-pig mesenteric artery.

Authors:  H Kuriyama; A Suyama
Journal:  J Physiol       Date:  1983-04       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.